Inactive

The 48 Medical Group (MDG) at RAF Lakenheath, United Kingdom, has a follow-on service contract requirement for a clinical pharmacist. This sources sought is for the purpose of determining how many con... The 48 Medical Group (MDG) at RAF Lakenheath, United Kingdom, has a follow-on service contract requirement for a clinical pharmacist. This sources sought is for the purpose of determining how many contractors are capable and/or willing to provide the 48 MDG with a clinical pharmacist.The period of performance will be from 1 Oct 2022 through 30 Sep 2027 on a one year base period and an additional four option periods. The primary job duties to be performed are consistent with standard commercial practices of a clinical pharmacist. Some, but not all, of the duties to be performed are as follows: - Assessing patient's response to drug therapy and planning drug therapy based on physician-established diagnoses. - Ordering and evaluating laboratory tests necessary to evaluate drug therapy effects and outcomes. - Initiating, modifying, or discontinuing medications for ongoing therapy of chronic disease states (e.g., hypertension, hyperlipidemia, anticoagulant, diabetes, asthma, refill clinics, etc.), in cooperation with the medical staff. - Monitoring and managing pharmacotherapy requiring periodic adjustment due to specific or changing pharmacokinetic characteristics (e.g., aminoglycosides, phenytoin, antithrombotics). - Initiating or modifying drug therapy for minor acute conditions such as colds, rashes, and allergies. - Administering prescription or non-prescription drugs according to established agreements or protocols. - Assessing metabolic needs and ordering therapeutic enteral or parenteral nutrition products in the inpatient setting. - Evaluating medical and medication histories for drug-related problems and adjusting drug therapy accordingly. - Consulting with other healthcare providers (e.g., physicians, dietitians, nurses, physical therapists, etc.) about patient treatment needs or options. - Conducting and coordinating clinical investigations and research (consistent with other healthcare professionals) approved by a local or regional Investigational Review Board (IRB) and participating in outcome studies generated by the department of pharmacy and approved by the P&T Committee. All responses to this sources sought will be treated as information only. Responses will not be used as a quote or offer. Comments, questions, and all other responses to this sources sought can be directed to the following: Amn Henry Kleemann henry.kleemann@us.af.mil (+44) 01638 523091 TSgt Trenton Beavers trenton.beavers@us.af.mil (+44) 01638 521222